Literature DB >> 8252043

Molecular analysis of new mutations for Huntington's disease: intermediate alleles and sex of origin effects.

Y P Goldberg1, B Kremer, S E Andrew, J Theilmann, R K Graham, F Squitieri, H Telenius, S Adam, A Sajoo, E Starr.   

Abstract

Huntington's disease (HD) is associated with expansion of a CAG repeat in a novel gene. We have assessed 21 sporadic cases of HD to investigate sequential events underlying HD. We show the existence of an intermediate allele (IA) in parental alleles of 30-38 CAG repeats in the HD gene which is greater than usually seen in the general population but below the range seen in patients with HD. These IAs are meiotically unstable and in the sporadic cases, expand to the full mutation associated with the phenotype of HD. This expansion has been shown to occur only during transmission through the male germline and is associated with advanced paternal age. These findings suggest that new mutations for HD are more frequent than prior estimates and indicate a previously unrecognized risk of inheriting HD to siblings of sporadic cases of HD and their children.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8252043     DOI: 10.1038/ng1093-174

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  64 in total

Review 1.  Friedreich ataxia: an overview.

Authors:  M B Delatycki; R Williamson; S M Forrest
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

Review 2.  Huntington disease--another chapter rewritten.

Authors:  M A Nance
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

3.  The CAG repeat at the Huntington disease gene in the Portuguese population: insights into its dynamics and to the origin of the mutation.

Authors:  Maria do Carmo Costa; Paula Magalhães; Laura Guimarães; Patrícia Maciel; Jorge Sequeiros; Alda Sousa
Journal:  J Hum Genet       Date:  2005-12-22       Impact factor: 3.172

4.  Incidence and mutation rates of Huntington's disease in Spain: experience of 9 years of direct genetic testing.

Authors:  M A Ramos-Arroyo; S Moreno; A Valiente
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

Review 5.  The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration.

Authors:  Julie Leegwater-Kim; Jang-Ho J Cha
Journal:  NeuroRx       Date:  2004-01

6.  Huntington's disease in Saudi Arabia.

Authors:  S Bohlega; D McLean; S Omer; Z al Kawi; R A Roos; M Losekoot; E Bakker
Journal:  J Med Genet       Date:  1995-04       Impact factor: 6.318

7.  Update on genetics of Huntington's disease: availability of direct and accurate predictive test.

Authors:  F Squitieri; G Campanella; M R Hayden
Journal:  Ital J Neurol Sci       Date:  1996-06

8.  A sporadic case of dentatorubral pallidoluysian atrophy (DRPLA) with CAG repeat expansion but no clinical abnormalities in the father.

Authors:  N Shimizu; T Yamami; M Nakayama; T Ikeuchi; R Koide; S Tsuji
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

9.  Molecular and clinical correlations in spinocerebellar ataxia type I: evidence for familial effects on the age at onset.

Authors:  L P Ranum; M Y Chung; S Banfi; A Bryer; L J Schut; R Ramesar; L A Duvick; A McCall; S H Subramony; L Goldfarb
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

10.  "Grasping the grey": patient understanding and interpretation of an intermediate allele predictive test result for Huntington disease.

Authors:  A Semaka; L G Balneaves; M R Hayden
Journal:  J Genet Couns       Date:  2012-08-18       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.